Congdon N, O’Colmain B, Klaver CCW, Klein R, Muñoz B, Friedman DS, et al. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol. 2004;122:477–85.

Article  PubMed  Google Scholar 

Bloch SB, Larsen M, Munch IC. Incidence of legal blindness from age-related macular degeneration in Denmark: year 2000 to 2010. Am J Ophthalmol. 2012;153:209– 13.e2.

Jonas JB, Cheung CMG, Panda-Jonas S. Updates on the epidemiology of age-related macular degeneration. Asia Pac J Ophthalmol (Phila). 2017;6:493–7.

PubMed  Google Scholar 

Barash A, Chui TYP, Garcia P, Rosen RB. Acute macular and peripapillary angiographic changes with intravitreal injections. Retina. 2020;40:648–56.

Article  PubMed  Google Scholar 

Pirinen I, Leinonen S, Helminen M, Hujanen P, Vaajanen A, Tuulonen A, et al. Glaucoma progression in patients receiving intravitreal anti-VEGF treatment for neovascular age-related macular degeneration. Acta Ophthalmol. 2023;101:261–5.

Article  PubMed  CAS  Google Scholar 

Baek SK, Kim JH, Kim JW, Kim CG. Increase in the population of patients with neovascular age-related macular degeneration who underwent long-term active treatment. Sci Rep. 2019;9:13264.

Article  PubMed  PubMed Central  Google Scholar 

Joussen AM, Ricci F, Paris LP, Korn C, Quezada-Ruiz C, Zarbin M. Angiopoietin/Tie2 signalling and its role in retinal and choroidal vascular diseases: a review of preclinical data. Eye (Lond). 2021;35:1305–16.

Article  PubMed  Google Scholar 

Regula JT, von Lundh P, Foxton R, Barathi VA, Cheung CMG, Bo Tun SB, et al. Targeting key angiogenic pathways with a bispecific CrossMAb optimized for neovascular eye diseases. EMBO Mol Med. 2016;8:1265–88.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Thomson BR, Heinen S, Jeansson M, Ghosh AK, Fatima A, Sung HK, et al. A lymphatic defect causes ocular hypertension and glaucoma in mice. J Clin Invest. 2014;124:4320–4.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Thomson BR, Souma T, Tompson SW, Onay T, Kizhatil K, Siggs OM, et al. Angiopoietin-1 is required for Schlemm’s canal development in mice and humans. J Clin Invest. 2017;127:4421–36.

Article  PubMed  PubMed Central  Google Scholar 

Souma T, Tompson SW, Thomson BR, Siggs OM, Kizhatil K, Yamaguchi S, et al. Angiopoietin receptor TEK mutations underlie primary congenital glaucoma with variable expressivity. J Clin Invest. 2016;126:2575–87.

Article  PubMed  PubMed Central  Google Scholar 

Kim J, Park D-Y, Bae H, Park DY, Kim D, Lee C-K, et al. Impaired angiopoietin/Tie2 signaling compromises Schlemm’s canal integrity and induces glaucoma. J Clin Invest. 2017;127:3877–96.

Article  PubMed  PubMed Central  Google Scholar 

Kapiainen E, Elamaa H, Miinalainen I, Izzi V, Eklund L. Cooperation of angiopoietin-2 and angiopoietin-4 in Schlemm’s canal maintenance. Invest Ophthalmol Vis Sci. 2022;63:1.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Freund KB, Hoang QV, Saroj N, Thompson D. Intraocular pressure in patients with neovascular age-related macular degeneration receiving intravitreal aflibercept or ranibizumab. Ophthalmology. 2015;122:1802–10.

Article  PubMed  Google Scholar 

Matsumoto H, Hoshino J, Nakamura K, Nagashima T, Akiyama H. Short-term outcomes of intravitreal faricimab for treatment-naïve neovascular age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 2023;261:2945–52.

Article  PubMed  CAS  Google Scholar 

Mukai R, Kataoka K, Tanaka K, Miyara Y, Maruko I, Nakayama M, et al. Three-month outcomes of faricimab loading therapy for wet age-related macular degeneration in Japan. Sci Rep. 2023;13:8747.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Gabrielle P-H, Nguyen V, Wolff B, Essex R, Young S, Hunt A, et al. Intraocular pressure changes and vascular endothelial growth factor inhibitor use in various retinal diseases: long-term outcomes in routine clinical practice: data from the Fight Retinal Blindness! Registry. Ophthalmol Retina. 2020;4:861–70.

Article  PubMed  Google Scholar 

Novais EA, Baumal CR, Sarraf D, Freund KB, Duker JS. Multimodal imaging in retinal disease: A consensus definition. Ophthalmic Surg Lasers Imaging Retina. 2016;47:201–5.

Article  PubMed  Google Scholar 

Yannuzzi NA, Patel SN, Bhavsar KV, Sugiguchi F, Freund KB. Predictors of sustained intraocular pressure elevation in eyes receiving intravitreal anti-vascular endothelial growth factor therapy. Am J Ophthalmol. 2014;158:319–e3272.

Article  PubMed  CAS  Google Scholar 

Ramsey DJ, McCullum JC, Steinberger EE, Zhang Y, Alwreikat AM, Cooper ML, et al. Intraocular pressure decreases in eyes with glaucoma-related diagnoses after conversion to aflibercept for treatment-resistant age-related macular degeneration. Eye (Lond). 2022;36:1813–9.

Article  PubMed  CAS  Google Scholar 

Rusu IM, Deobhakta A, Yoon D, Lee M, Slakter JS, Klancnik JM, et al. Intraocular pressure in patients with neovascular age-related macular degeneration switched to aflibercept injection after previous anti-vascular endothelial growth factor treatments. Retina. 2014;34:2161–6.

Article  PubMed  CAS  Google Scholar 

Honjo J, Mukai R, Itagaki K, Tanaka K, Norikawa K, Kato Y, et al. Intraocular pressure changes during intravitreal aflibercept injection based on treat-and-extend regimen in Japanese patients with neovascular age-related macular degeneration and glaucoma. Jpn J Ophthalmol. 2024;68:91–5.

Article  PubMed  CAS  Google Scholar 

Fogli S, Del Re M, Rofi E, Posarelli C, Figus M, Danesi R. Clinical pharmacology of intravitreal anti-VEGF drugs. Eye (Lond). 2018;32:1010–20.

Article  PubMed  CAS  Google Scholar 

Van Bergen T, Jonckx B, Hollanders K, Sijnave D, Van de Velde S, Vandewalle E, et al. Inhibition of placental growth factor improves surgical outcome of glaucoma surgery. J Cell Mol Med. 2013;17:1632–43.

Article  PubMed  PubMed Central  Google Scholar 

Van Bergen T, Etienne I, Cunningham F, Moons L, Schlingemann RO, Feyen JHM, et al. The role of placental growth factor (PlGF) and its receptor system in retinal vascular diseases. Prog Retin Eye Res. 2019;69:116–36.

Article  PubMed  Google Scholar 

Batchelor TT, Sorensen AG, di Tomaso E, Zhang W-T, Duda DG, Cohen KS, et al. AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients. Cancer Cell. 2007;11:83–95.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Heier JS, Khanani AM, Quezada Ruiz C, Basu K, Ferrone PJ, Brittain C, et al. Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and Lucerne): two randomised, double-masked, phase 3, non-inferiority trials. Lancet. 2022;399:729–40.

Article  PubMed  CAS  Google Scholar 

Khawaja AP, Cooke Bailey JN, Wareham NJ, Scott RA, Simcoe M, Igo RP, et al. Genome-wide analyses identify 68 new loci associated with intraocular pressure and improve risk prediction for primary open-angle glaucoma. Nat Genet. 2018;50:778–82.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Thackaberry EA, Zhou Y, Zuch de Zafra CL, Fuh G, Lee CV, Sanowar S, et al. Rapid development of glaucoma via ITV nonselective ANGPT 1/2 antibody: A potential role for ANGPT/Tie2 signaling in primate aqueous humor outflow. Invest Ophthalmol Vis Sci. 2019;60:4097–108.

Article  PubMed  CAS  Google Scholar